An underground market for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Followers are encouraged to contact these accounts privately for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Additionally, a robust market exists on messaging services, where communities with thousands of participants share comparison images, injection guides and assertions of rapid British shipping. Vendors market the drug there before directing buyers to other platforms for transactions.
Learning About Retatrutide
This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Professionals Express Concerns
Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to users administering substances of uncertain source.
Some professionals stated the popularity for retatrutide could be connected to the rising cost of licensed slimming products such as Mounjaro.
Legal Position and Implementation
Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach medicines, marketing, and consumer regulations, risking fines, prosecution or imprisonment.
Service Response and Material Elimination
Based on TikTok, the service has taken down problematic content and prohibited related hashtags and search suggestions. The organization stated it was committed to maintaining the platform secure and allocating resources in strengthening compliance measures.
Digital Marketplace Activities
Research also found communities with up to 9,000 participants selling the experimental drug using the platform's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, filled with images of weight loss, positive reviews and detailed instructions for preparing or administering at residence.
Within minutes of joining one community, a seller posted WhatsApp details, where the majority of purchases occur. The vendor sent an guidebook and promised delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or previous experience.
Item Details and Pricing
Within these groups, messages show black plastic packages with postal service labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with purified liquid, or pre-filled pens typically sold at 160 pounds for 20 milligrams. When asked how much time a pen should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A representative for Telegram said it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering materials they cannot confirm. Even if the research behind this drug is valid, these online versions may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service linked the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake injections are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.
Her staff has already encountered individuals injured by personal administration from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company investigational product not yet approved … may expose patients to potentially significant health risks”.
